1. Home
  2. Research
  3. Research Groups
  4. Drug utilisation and health outcomes of pharmacotherapy

Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Hernández-García M, Nieto-Torres M, Guerra-Pinto N, Castillo-Polo JA, Saez de la Fuente J, Michelena M, Ponce-Alonso M, Soriano-Cuesta C, Díaz-Agero C, Cantón R, Coque TM, Ruiz-Garbajosa P.

    ICU environment as a reservoir of KPC-ST307-Klebsiella pneumoniae high-risk clone resistant to ceftazidime-avibactam.

    SCIENTIFIC REPORTS . 15(1): 29486-29486.

    [doi:10.1038/s41598-025-14987-w]

  • Fortún J, Rodríguez-Gandía MA, Pintado V, Martín-Dávila P, García-González M, Graus J, Martín-Mateos R, Fuente JS, Muriel A, Moreno S.

    Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study.

    Infection . 53(3): 1219-1225.

    [doi:10.1007/s15010-025-02491-2]

  • Alonso-Gordoa T, Anguera G, Domínguez-Esteban M, Reig Ò, Martínez-Barros H, Molina-Cerrillo J, Cruz P, Maroto P.

    Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies.

    CANCER TREATMENT REVIEWS . 136: 102925-102925.

    [doi:10.1016/j.ctrv.2025.102925]

  • Rosas Cancio-Suárez M, Moreno A, del Campo Terrón S, Vivancos MJ, G García-Ruiz De Morales A, Martínez-Sanz J, Ron R, Sánchez-Izquierdo S, Vélez-Díaz-Pallarés M, Moreno S, Pérez-Elías MJ.

    Real-world efficacy and tolerability of CAB+RPV LA in women: addressing the gender gap in HIV treatment research.

    The Journal of antimicrobial chemotherapy . 80(4): 1084-1088.

    [doi:10.1093/jac/dkaf038]

  • Rodríguez Sagrado MA, Alvarez Criado J, Arenaza Peña AE, Escudero-Vilaplana V, Folguera Olias C, Herrero Fernandez M, Martinez Nieto C, Rubio Salvador AR, Sanmartin Fenollera P, Vazquez Castillo MJ.

    Niraparib Maintenance Therapy in Patients with Platinum-Sensitive Recurrent Ovarian Cancer: Real-World Experience at Hospitals in Spain.

    TARGETED ONCOLOGY . 20(2): 319-327.

    [doi:10.1007/s11523-024-01121-5]

  • Verdugo RM, Ferrán BB, Polo AF, Framiñan LM, Sesmero JMM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

    [Translated article] Prioritisation of 2024-2027 initiatives of the strategic Map for outpatient pharmaceutical care of the Spanish Society of Hospital Pharmacy.

    FARMACIA HOSPITALARIA . 49(1): .

    [doi:10.1016/j.farma.2024.08.003]

  • Montero-Llorente B, Pérez Menéndez-Conde C, González Ferrer E, López Castellanos GT, Bedoya Del Olmo LM, Bermejo Vicedo T.

    Impact of pharmaceutical care on hospital readmissions for heart failure: a randomised trial.

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY . : .

    [doi:10.1136/ejhpharm-2024-004218]

  • Martínez-Barros H, Pousada-Fonseca Á, Pedreira-Bouzas J, Clopés-Estela A.

    Characteristics, clinical benefit and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020.

    FARMACIA HOSPITALARIA . 48(6): 272-277.

    [doi:10.1016/j.farma.2024.04.022]

  • Buti M, Calleja JL, Rodríguez MÁ, Domínguez-Hernández R, Cantero H, Espinoza-Cámac N, Casado MÁ.

    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D.

    GASTROENTEROLOGIA Y HEPATOLOGIA . : 502241-502241. Number of citations: 1

    [doi:10.1016/j.gastrohep.2024.502241]

  • PARRO MARTÍN, MARÍA DE LOS ÁNGELES.

    Guide for the efficient and safe delivery of Telepharmacy

    Health Policy and Technology . : .

    [doi:https://doi.org/10.1016/j.hlpt.2024.100899]

  • Fernández de Gamarra-Martínez E, Tortajada-Goitia B, Corte-García JJ, Martín-Herranz I, García-Gil M, Sáez de la Fuente J, Nicolás-Picó J.

    [Translated article] Hospital pharmacy towards 2030.

    FARMACIA HOSPITALARIA . 48 Suppl 1: 52-58.

    [doi:10.1016/j.farma.2024.06.008]

  • Fernández de Gamarra-Martínez E, Tortajada-Goitia B, Corte-García JJ, Martín-Herranz I, García-Gil M, Sáez de la Fuente J, Nicolás-Picó J.

    Hospital pharmacy towards 2030.

    FARMACIA HOSPITALARIA . 48 Suppl 1: 52-58.

    [doi:10.1016/j.farma.2024.05.004]

  • Fernández-Fradejas J, Delgado-Silveira E, González-Burgos E, Álvarez-Díaz AM, Vélez-Díaz-Pallarés M.

    Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV.

    HIV MEDICINE . 25(5): 587-599.

    [doi:10.1111/hiv.13616]

  • Meijon-Ortigueira MDM, Solares I, Muñoz-Delgado C, Stanescu S, Morado M, Pascual-Izquierdo C, Villalon Blanco L, Belanger Quintana A, Menéndez-Conde CP, Morales-Conejo M, Villarrubia-Espinosa J.

    Women with Gaucher Disease.

    Biomedicines . 12(3): .

    [doi:10.3390/biomedicines12030579]

  • Fortún J, Gómez-García de la Pedrosa E, Martínez-Lorca A, Paredes P, Martín-Dávila P, Gómez-López A, Buitrago MJ, López-Jiménez J, Gioia F, Escudero R, Alvarez-Alvarez ME, Soriano C, Moreno-García J, San Miguel D, Vicente N, Moreno S.

    A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis.

    JOURNAL OF FUNGI . 10(3): . Number of citations: 1

    [doi:10.3390/jof10030191]

  • Fernández-Fradejas J, Martínez-Barros H, Rexach-Cano L, Álvarez-Díaz AM, Delgado-Silveira E.

    Deprescribing in older patients with advanced cancer referred to palliative care.

    BMJ Supportive & Palliative Care . : .

    [doi:10.1136/spcare-2024-004849]

  • Herrero Domínguez-Berrueta MC, Muñoz-García M, Delgado-Silveira E, Martín-Aragón S, Gangoso Fermoso A.

    Primary care pharmacist-led medication review in older adult patients in coordination with general practitioners: an observational retrospective cohorts study.

    Exploratory Research In Clinical And Social Pharmacy . 13: 100390-100390. Number of citations: 1

    [doi:10.1016/j.rcsop.2023.100390]

  • Esteban-Cartelle B, Serrano DR, Pérez Menéndez-Conde C, Vicente-Oliveros N, Álvarez-Díaz A, Abete JF, Martín-Dávila P.

    Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

    Microbiology spectrum . 12(2): .

    [doi:10.1128/spectrum.02063-23]